《Journal Of Psychoactive Drugs》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱精神藥物學(xué)雜志,本刊主要出版、報(bào)道醫(yī)學(xué)-PSYCHOLOGY, CLINICAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE、SSCI收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.1,最新CiteScore 指數(shù)為5.3。
英文介紹
Journal Of Psychoactive Drugs雜志英文介紹
The Journal of Psychopharmacology is an academic journal dedicated to the field of psychopharmacology, covering both basic and clinical research on psychotropic drugs. This magazine provides a platform for medical professionals to exchange the latest research findings and academic insights, including original research, reviews, case reports, as well as clinical and preclinical studies. The magazine pays special attention to the drug treatment of major mental illnesses, such as the efficacy and side effects of antipsychotics, mood stabilizers, and antidepressants, as well as exploring new drug targets and neural circuits.
The magazine encourages the use of biological markers, such as genetic markers, structural and functional imaging, neurocognitive function, etc., to evaluate drug efficacy. At the same time, attention is also paid to the research of individualized treatment plans, as well as drug research targeting inflammation and immunity, as these may play a certain role in the pathogenesis of mental illnesses. In addition, the magazine emphasizes the importance of precision medicine, especially in the fields of therapeutic drug monitoring and pharmacogenomics.